+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
U.S. Breast Biopsy Devices Market Size, Share & Trends Analysis Report by Product Type, Procedure Type, Guidance Technology, End Use, and Segment Forecasts, 2026-2033- Product Image
U.S. Breast Biopsy Devices Market Size, Share & Trends Analysis Report by Product Type, Procedure Type, Guidance Technology, End Use, and Segment Forecasts, 2026-2033- Product Image
New

U.S. Breast Biopsy Devices Market Size, Share & Trends Analysis Report by Product Type, Procedure Type, Guidance Technology, End Use, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 110 Pages
  • February 2026
  • Region: United States
  • Grand View Research
  • ID: 6228032
REQUEST CUSTOMIZATION
Description Jump to:
The U.S. breast biopsy devices market size was estimated at USD 1.18 billion in 2025 and is anticipated to reach USD 1.60 billion by 2033, growing at a CAGR of 3.9% from 2026 to 2033. The market growth driven by the rising incidence of breast cancer and the consequent emphasis on early detection and accurate diagnosis, which increases the volume of biopsy procedures required in screening and diagnostic pathways.

High awareness among patients and clinicians, supported by structured screening programs and favorable reimbursement landscapes, further propels device adoption. In addition, technological advancements, including minimally invasive core-needle and vacuum-assisted systems, integration with advanced imaging modalities (e.g., ultrasound, MRI, 3D mammography), and AI-enhanced diagnostic workflows, are expanding clinical utility, improving procedural accuracy and patient comfort, and encouraging broader clinical integration.

The rising prevalence of breast cancer in the U.S. directly drives growth in the breast biopsy devices market because a higher number of new and suspected cancer cases increases the demand for diagnostic confirmation through tissue sampling. In the U.S., breast cancer is the most commonly diagnosed cancer among women, with hundreds of thousands of new invasive and non-invasive cases reported annually, prompting more routine screening and follow-up biopsies when abnormalities are detected on imaging. As incidence rates climb and screening programs expand, healthcare providers perform more biopsies to confirm diagnoses, guide treatment decisions, and rule out malignancy, thereby boosting utilization of core-needle, vacuum-assisted, and image-guided breast biopsy devices.

As screening programs such as mammography and MRI expand, more suspicious lesions are detected, necessitating tissue sampling via core-needle or vacuum-assisted biopsy. This sustained rise in diagnostic volumes increases demand for advanced, image-guided biopsy systems in hospitals and ambulatory centers. The link between higher case detection and device innovation is evident in recent industry developments, for instance, in February 2026, Mammotome, a part of Danaher Corporation, introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System, the first system designed to be positioned inside the MRI scanner room at the patient’s side during biopsy. By improving clinician coordination and workflow efficiency in MRI-guided procedures, such innovations address the growing procedural burden driven by rising breast cancer prevalence, thereby accelerating technology adoption and overall market growth in the U.S. breast biopsy devices sector.

U.S. Breast Biopsy Devices Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, the analyst has segmented the U.S. breast biopsy devices market report based on product, procedure type, guidance technology, and end use:

Product Type Outlook (Revenue, USD Million, 2021-2033)

  • Biopsy Guidance Systems
  • Core Needle Biopsy (CNB) Guns
  • Biopsy Tables
  • Biopsy Consumables"U" Shape" Shape
  • Other Consumables

Procedure Type Outlook (Revenue, USD Million, 2021-2033)

  • Vacuum-Assisted Biopsy (VAB)
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration Biopsy (FNAB)
  • Surgical (Open) Biopsy
  • Liquid Biopsy

Guidance Technology Outlook (Revenue, USD Million, 2021-2033)

  • Ultrasound-Guided
  • Mammography / Stereotactic-Guided
  • MRI-Guided

End Use Outlook (Revenue, USD Million; 2021-2033)

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Breast Care Centers
  • Diagnostic Centers/Imaging Centers

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Product
1.1.2. Procedure Type
1.1.3. Guidance Technology
1.1.4. End Use
1.1.5. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.5. Details of primary research
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Breast Biopsy Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing burden of breast cancer
3.2.1.2. Expansion of breast cancer screening programs
3.2.1.3. Technological advancements in imaging-guided biopsy
3.2.2. Market Restraints Analysis
3.2.2.1. High cost of advanced biopsy technologies
3.2.2.2. Limited access to diagnostic facilities in low-resource settings
3.2.3. Market Opportunity Analysis
3.2.3.1. Expansion of screening programs in emerging economies
3.2.3.2. Growth of minimally invasive and rapid diagnostic technologies
3.2.3.3. Integration with next-generation imaging and AI
3.2.3.4. Expansion of outpatient and ambulatory care
3.2.3.5. Rising demand for personalized and precision diagnostics
3.2.4. Market Challenge Analysis
3.2.4.1. Patient anxiety and procedure hesitation
3.2.4.2. Limited skilled workforce
3.3. U.S. Breast Biopsy Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. U.S. Breast Biopsy Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Breast Biopsy Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
4.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.3.1. Biopsy Guidance Systems
4.3.1.1. Biopsy guidance systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2. Biopsy Drivers & Handpieces
4.3.2.1. Biopsy drivers & handpieces market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.2. Vacuum-assisted biopsy (VAB) drivers
4.3.2.2.1. Vacuum-assisted biopsy (VAB) drivers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3. Core needle biopsy (CNB) guns
4.3.2.3.1. Core needle biopsy (CNB) guns market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3.2. Automated
4.3.2.3.2.1. Automated market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3.3. Semi-automated
4.3.2.3.3.1. Semi-automated market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3. Biopsy tables
4.3.3.1. Biopsy tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3.2. Prone tables
4.3.3.2.1. Prone tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3.3. Upright/add-on tables
4.3.3.3.1. Upright/add-on tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4. Biopsy consumables
4.3.4.1. Biopsy consumables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.2. Needles & probes
4.3.4.2.1. Needles & probes market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3. Site markers & clips
4.3.4.3.1. Site markers & clips market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.2. By shape/design
4.3.4.3.2.1. By shape/design market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3. Standard geometric markers
4.3.4.3.3.1. Standard geometric markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.2. Ring
4.3.4.3.3.2.1. Ring market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.3. Cross
4.3.4.3.3.3.1. Cross market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.4. Ribbon
4.3.4.3.3.4.1. Ribbon market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.5. Others
4.3.4.3.3.5.1. Others markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4. Advanced anchoring markers
4.3.4.3.4.1. Advanced anchoring markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.2. Anchor
4.3.4.3.4.2.1. Anchor markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.3. Wing, "U" shape
4.3.4.3.4.3.1. Wing, "U" shape market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.4. "Q" shape
4.3.4.3.4.4.1. "Q" shape markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5. 3D / expandable markers
4.3.4.3.5.1. 3D / expandable markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.2. 3D ribbon
4.3.4.3.5.2.1. 3D ribbon market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.3. 3D sphere
4.3.4.3.5.3.1. 3D Sphere market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.4. 3D Mesh
4.3.4.3.5.4.1. 3D Mesh market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4. Localization systems
4.3.4.4.1. Localization systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4.2. Traditional wires
4.3.4.4.2.1. Traditional wires market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4.3. Wireless Seeds-RFID/magnetic
4.3.4.4.3.1. Wireless seeds-RFID/magnetic market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.5. Other Consumables
4.3.5.1. Other consumables market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. U.S. Breast Biopsy Devices Market: Procedure Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Breast Biopsy Devices Market: Procedure Type Movement Analysis, 2025 & 2033 (USD Million)
5.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Procedure Type, 2021 to 2033 (USD Million)
5.3.1. Vacuum-Assisted Biopsy (VAB)
5.3.1.1. Vacuum-assisted biopsy (VAB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.2. Core Needle Biopsy (CNB)
5.3.2.1. Core needle biopsy (CNB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.3. Fine Needle Aspiration Biopsy (FNAB)
5.3.3.1. Fine needle aspiration biopsy (FNAB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.4. Surgical (Open) Biopsy
5.3.4.1. Surgical (open) biopsy market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.5. Liquid Biopsy
5.3.5.1. Liquid biopsy market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. U.S. Breast Biopsy Devices Market: Guidance Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Breast Biopsy Devices Market: Guidance Technology Movement Analysis, 2025 & 2033 (USD Million)
6.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Guidance Technology, 2021 to 2033 (USD Million)
6.3.1. Ultrasound-Guided
6.3.1.1. Ultrasound-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
6.3.2. Mammography / Stereotactic-Guided
6.3.2.1. Mammography / stereotactic-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
6.3.3. MRI-Guided
6.3.3.1. MRI-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. U.S. Breast Biopsy Devices Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Breast Biopsy Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
7.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
7.3.1. Hospitals
7.3.1.1. Hospitals market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.2. Ambulatory Surgical Centers (ASCs)
7.3.2.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.3. Specialized Breast Care Centers
7.3.3.1. Specialized breast care centers market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.4. Diagnostic Centers/Imaging Centers
7.3.4.1. Diagnostic centers/imaging centers market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Market Share Analysis, 2025
8.4. Company Heat Map Analysis
8.5. Strategy Mapping
8.5.1. Expansion
8.5.2. Mergers & Acquisition
8.5.3. Partnerships & Collaborations
8.5.4. New Product Launches
8.5.5. Research And Development
8.5.6. Company Profiles
8.5.7. Hologic, Inc.
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Mammotome (Danaher)
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic initiatives
8.5.9. BD
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Argon Medical
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Merit Medical Systems
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic initiatives
8.5.12. GE HealthCare
8.5.12.1. Company overview
8.5.12.2. Financial performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic initiatives
8.5.13. Cook Medical
8.5.13.1. Company overview
8.5.13.2. Financial performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic initiatives
8.5.14. MOLLI Surgical (Stryker)
8.5.14.1. Company overview
8.5.14.2. Financial performance
8.5.14.3. Product Benchmarking
8.5.14.4. Strategic initiatives
8.5.15. Planmed Oy
8.5.15.1. Company overview
8.5.15.2. Financial performance
8.5.15.3. Product Benchmarking
8.5.15.4. Strategic initiatives
8.5.16. Siemens Healthineers
8.5.16.1. Company overview
8.5.16.2. Financial performance
8.5.16.3. Product Benchmarking
8.5.16.4. Strategic initiatives
8.5.17. Fujifilm Healthcare
8.5.17.1. Company overview
8.5.17.2. Financial performance
8.5.17.3. Product Benchmarking
8.5.17.4. Strategic initiatives
8.5.18. INRAD
8.5.18.1. Company overview
8.5.18.2. Financial performance
8.5.18.3. Product Benchmarking
8.5.18.4. Strategic initiatives
8.5.19. Resitu Medical
8.5.19.1. Company overview
8.5.19.2. Financial performance
8.5.19.3. Product Benchmarking
8.5.19.4. Strategic initiatives
8.5.20. TransMed7, LLC.
8.5.20.1. Company overview
8.5.20.2. Financial performance
8.5.20.3. Product Benchmarking
8.5.20.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 U.S. breast biopsy devices market, by product type 2021-2033 (USD Million)
Table 3 U.S. breast biopsy devices market, by procedure type 2021-2033 (USD Million)
Table 4 U.S. breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 5 U.S. breast biopsy devices market, by end use 2021-2033 (USD Million)
List of Figures
Figure 1 U.S. breast biopsy devices market segmentation.
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Data analysis models
Figure 5 Market formulation and validation
Figure 6 Data validating & publishing.
Figure 7 Market snapshot
Figure 8 Segment snapshot.
Figure 9 Competitive landscape snapshot
Figure 10 U.S. breast biopsy devices - market size and growth prospects (USD Million)
Figure 11 U.S. breast biopsy devices market: Industry Value Chain Analysis
Figure 12 U.S. breast biopsy devices market: Market Dynamics
Figure 13 U.S. breast biopsy devices market: PORTER’s Analysis
Figure 14 U.S. breast biopsy devices market: PESTEL Analysis
Figure 15 U.S. breast biopsy devices market share by product type, 2025 & 2033 (USD Million)
Figure 16 Breast biopsy devices market, by product type: market share, 2025 & 2033.
Figure 17 Biopsy guidance systems market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 18 Biopsy drivers & handpieces market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 19 Vacuum-assisted biopsy (VAB) drivers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 20 Core needle biopsy (CNB) guns market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 21 Automated market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 22 Semi-automated market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 23 Biopsy tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 24 Prone tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 25 Upright/add-on tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 26 Biopsy consumables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 27 Needles & probes market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 28 Site markers & clips market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 29 By shape/design market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 30 Standard geometric markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 31 Ring market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 32 Cross market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 33 Others market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 34 Advanced anchoring markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 35 Anchor market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 36 Wing, "U" shape market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 37 "Q" shape market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 38 3D / expandable markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 39 3D ribbon market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 40 3D sphere market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 41 3D mesh market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 42 Localization systems market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 43 Traditional wires market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 44 Wireless seeds-RFID/magnetic market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 45 Other consumables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 46 U.S. breast biopsy devices market share by procedure type, 2025 & 2033 (USD Million)
Figure 47 U.S. breast biopsy devices market, by procedure type: market share, 2025 & 2033.
Figure 48 Vacuum-assisted biopsy (VAB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 49 Core needle biopsy (CNB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 50 Fine needle aspiration biopsy (FNAB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 51 Surgical (open) biopsy market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 52 Liquid biopsy market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 53 U.S. breast biopsy devices market share by guidance technology, 2025 & 2033 (USD Million)
Figure 54 U.S. breast biopsy devices market, by guidance technology: market share, 2025 & 2033.
Figure 55 Ultrasound-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 56 Mammography / stereotactic-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 57 MRI-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 58 U.S. breast biopsy devices market share by end use, 2025 & 2033 (USD Million)
Figure 59 U.S. breast biopsy devices market, by end use: market share, 2025 & 2033.
Figure 60 Hospitals market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 61 Ambulatory surgical centers (ASCs) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 62 Specialized breast care centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 63 Diagnostic centers/imaging centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 64 Key company categorization
Figure 65 Company market positioning
Figure 66 Key company market share analysis, 2025
Figure 67 Strategic framework

Companies Mentioned

The leading players profiled in this U.S. Breast Biopsy Devices market report include:
  • Hologic, Inc.
  • Mammotome (Danaher)
  • BD
  • Argon Medical
  • Merit Medical Systems
  • GE HealthCare
  • Cook Medical
  • MOLLI Surgical (Stryker)
  • Planmed Oy
  • Siemens Medical Solutions USA, Inc.
  • Fujifilm Healthcare
  • INRAD
  • Resitu Medical
  • TransMed7, LLC.

Table Information

Report AttributeDetails
No. of Pages110
PublishedFebruary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 1.18 Billion
Forecasted Market Value ( USD ) by 2033 $ 1.6 Billion
Compound Annual Growth Rate3.9%
Regions CoveredUnited States
No. of Companies Mentioned15

Related Topics

Related Reports

Cancer Biopsy Market Forecast to 2033 - Product Image

Cancer Biopsy Market Forecast to 2033

  • Report
  • 120 Pages
  • Global
From
Breast-conserving Surgery Market Size, Share & Trends Analysis Report By Procedure (Lumpectomy, Quadrantectomy, Segmental Mastectomy), By Product (Margin Assessment Devices), By End-use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Breast-conserving Surgery Market Size, Share & Trends Analysis Report By Procedure (Lumpectomy, Quadrantectomy, Segmental Mastectomy), By Product (Margin Assessment Devices), By End-use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 118 Pages
  • Global
From
Breast Tissue Markers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Breast Tissue Markers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 189 Pages
  • Global
From
Breast Biopsy Devices Market by Product, Procedure, Application, End User - Global Forecasts to 2030 - Product Image

Breast Biopsy Devices Market by Product, Procedure, Application, End User - Global Forecasts to 2030

  • Report
  • 290 Pages
  • Global
From
Biopsy Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Biopsy Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.